Cargando…

Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions

BACKGROUND: Matrix metalloproteinases (MMPs) are enzymes that degrade all the components of extra cellular matrix and collagen. Various types of MMPs are known to be expressed and activated in patients with oral submucous fibrosis (OSMF) as well as head and neck squamous cell carcinoma (HNSCC). The...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhary, Ajay K, Singh, Mamta, Bharti, Alok C, Singh, Mangal, Shukla, Shirish, Singh, Atul K, Mehrotra, Ravi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912870/
https://www.ncbi.nlm.nih.gov/pubmed/20630073
http://dx.doi.org/10.1186/1471-2407-10-369
_version_ 1782184639780093952
author Chaudhary, Ajay K
Singh, Mamta
Bharti, Alok C
Singh, Mangal
Shukla, Shirish
Singh, Atul K
Mehrotra, Ravi
author_facet Chaudhary, Ajay K
Singh, Mamta
Bharti, Alok C
Singh, Mangal
Shukla, Shirish
Singh, Atul K
Mehrotra, Ravi
author_sort Chaudhary, Ajay K
collection PubMed
description BACKGROUND: Matrix metalloproteinases (MMPs) are enzymes that degrade all the components of extra cellular matrix and collagen. Various types of MMPs are known to be expressed and activated in patients with oral submucous fibrosis (OSMF) as well as head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to asses the association of the single nucleotide polymorphism (SNP) adenosine insertion/deletion polymorphism (-1171 5A->6A) in the MMP-3 promoter region in these lesions. METHODS: MMP-3 SNP was genotyped by polymerase chain reaction-restriction fragment polymorphism (PCR-RFLP) analysis in a case control study consisting of 362 participants; 101 cases of OSMF, 135 of HNSCC and 126 controls, compared for age, sex and habits. ROC distribution was plotted to assess the contributions of genetic variation in MMP-3 genotypes with relation to age. RESULTS: Analysis of MMP 3 (-1171 5A->6A) polymorphism revealed the frequency of 5A allele in OSMF, HNSCC and controls to be 0.15, 0.13 and 0.07, respectively. A significant difference was found in 5A genotype frequency between OSMF (5A genotype frequency = 0.15, p = 0.01, OR = 2.26, 95% CI = 1.22-4.20) and in controls (5A genotype frequency 0.07) as well as HNSCC (5A genotype frequency 0.13, p = 0.03,95%CI = 1.06-3.51) and controls (5A genotype frequency = 0.07) In this study, 5A genotype had greater than two fold risk for developing OSMF (OR = 2.26) and nearly the same in case of HNSCC (OR = 1.94) as compared to controls. In patients with OSMF as well as HNSCC, the ROC analysis between the MMP-3 genotype and age, 6A/6A allele was found to be significant in patients both over and under 45 years of age; while the 5A/5A carrier alleles showed an association only in patients less than 45 years of age. CONCLUSIONS: This study concluded that the expression of MMP-3 genotype associated with the 5A alleles, it may have an important role in the susceptibility of the patients to develop OSMF and HNSCC.
format Text
id pubmed-2912870
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29128702010-07-31 Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions Chaudhary, Ajay K Singh, Mamta Bharti, Alok C Singh, Mangal Shukla, Shirish Singh, Atul K Mehrotra, Ravi BMC Cancer Research Article BACKGROUND: Matrix metalloproteinases (MMPs) are enzymes that degrade all the components of extra cellular matrix and collagen. Various types of MMPs are known to be expressed and activated in patients with oral submucous fibrosis (OSMF) as well as head and neck squamous cell carcinoma (HNSCC). The purpose of this study was to asses the association of the single nucleotide polymorphism (SNP) adenosine insertion/deletion polymorphism (-1171 5A->6A) in the MMP-3 promoter region in these lesions. METHODS: MMP-3 SNP was genotyped by polymerase chain reaction-restriction fragment polymorphism (PCR-RFLP) analysis in a case control study consisting of 362 participants; 101 cases of OSMF, 135 of HNSCC and 126 controls, compared for age, sex and habits. ROC distribution was plotted to assess the contributions of genetic variation in MMP-3 genotypes with relation to age. RESULTS: Analysis of MMP 3 (-1171 5A->6A) polymorphism revealed the frequency of 5A allele in OSMF, HNSCC and controls to be 0.15, 0.13 and 0.07, respectively. A significant difference was found in 5A genotype frequency between OSMF (5A genotype frequency = 0.15, p = 0.01, OR = 2.26, 95% CI = 1.22-4.20) and in controls (5A genotype frequency 0.07) as well as HNSCC (5A genotype frequency 0.13, p = 0.03,95%CI = 1.06-3.51) and controls (5A genotype frequency = 0.07) In this study, 5A genotype had greater than two fold risk for developing OSMF (OR = 2.26) and nearly the same in case of HNSCC (OR = 1.94) as compared to controls. In patients with OSMF as well as HNSCC, the ROC analysis between the MMP-3 genotype and age, 6A/6A allele was found to be significant in patients both over and under 45 years of age; while the 5A/5A carrier alleles showed an association only in patients less than 45 years of age. CONCLUSIONS: This study concluded that the expression of MMP-3 genotype associated with the 5A alleles, it may have an important role in the susceptibility of the patients to develop OSMF and HNSCC. BioMed Central 2010-07-14 /pmc/articles/PMC2912870/ /pubmed/20630073 http://dx.doi.org/10.1186/1471-2407-10-369 Text en Copyright ©2010 Chaudhary et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chaudhary, Ajay K
Singh, Mamta
Bharti, Alok C
Singh, Mangal
Shukla, Shirish
Singh, Atul K
Mehrotra, Ravi
Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions
title Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions
title_full Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions
title_fullStr Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions
title_full_unstemmed Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions
title_short Synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5A->6A) polymorphism in oral submucous fibrosis and head and neck lesions
title_sort synergistic effect of stromelysin-1 (matrix metalloproteinase-3) promoter (-1171 5a->6a) polymorphism in oral submucous fibrosis and head and neck lesions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912870/
https://www.ncbi.nlm.nih.gov/pubmed/20630073
http://dx.doi.org/10.1186/1471-2407-10-369
work_keys_str_mv AT chaudharyajayk synergisticeffectofstromelysin1matrixmetalloproteinase3promoter11715a6apolymorphisminoralsubmucousfibrosisandheadandnecklesions
AT singhmamta synergisticeffectofstromelysin1matrixmetalloproteinase3promoter11715a6apolymorphisminoralsubmucousfibrosisandheadandnecklesions
AT bhartialokc synergisticeffectofstromelysin1matrixmetalloproteinase3promoter11715a6apolymorphisminoralsubmucousfibrosisandheadandnecklesions
AT singhmangal synergisticeffectofstromelysin1matrixmetalloproteinase3promoter11715a6apolymorphisminoralsubmucousfibrosisandheadandnecklesions
AT shuklashirish synergisticeffectofstromelysin1matrixmetalloproteinase3promoter11715a6apolymorphisminoralsubmucousfibrosisandheadandnecklesions
AT singhatulk synergisticeffectofstromelysin1matrixmetalloproteinase3promoter11715a6apolymorphisminoralsubmucousfibrosisandheadandnecklesions
AT mehrotraravi synergisticeffectofstromelysin1matrixmetalloproteinase3promoter11715a6apolymorphisminoralsubmucousfibrosisandheadandnecklesions